FdaApplication
BLA 761238
Identifiers
- fda_app_no: BLA761238
Properties
| Property | Value |
|---|---|
| applicant_name | TG Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2022-12-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BRIUMVI | UBLITUXIMAB-XIIY | 150MG/6ML (25MG/ML) | Injection |
1 product